Tenderwize
Back to tender search

Pharmaceutical discount agreements for Tamsulosin and dutasteride

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Mar 31, 2027 · 131 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Tamsulosin und Dutasterid, ATC G04CA52

57/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

57 / 100

Complexity

64 / 100

Risk factors

The notice provides no value, volume, demand forecast or guaranteed spend, so the commercial return cannot be assessed...

Open-house contracts may be automatically terminated if exclusive rebate contracts enter into force during the contract...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Country
Germany
CPV
33600000 - Pharmaceutical products
Deadline
Mar 31, 2027

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration until May 2027
  • Supply of pharmaceutical products covered by non-exclusive rebate agreements for the active substances Tamsulosin and Dutasteride, ATC G04CA52.
  • Only medicines approved and marketable in Germany may be supplied.
Show full summary

Open-house, non-exclusive pharmaceutical rebate agreements for Tamsulosin and Dutasteride (ATC G04CA52) offered by AOK Rheinland-Pfalz/Saarland to all interested pharmaceutical companies meeting the stated regulatory conditions. There is no selection decision or individual negotiation; uniform contractual terms apply. Participation is possible monthly during the maximum 24-month period, subject to timely receipt of original documents. The notice states that this is not a public procurement under Directive 2014/24/EU, despite use of a standard open-procedure notice form. No contract value is provided, and the procurement documents were not substantively analyzed beyond the extracted XML notice.

Risks

The notice provides no value, volume, demand forecast or guaranteed spend, so the commercial return cannot be assessed...

Open-house contracts may be automatically terminated if exclusive rebate contracts enter into force during the contract...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • Participation is open to interested pharmaceutical companies without a selection decision.
  • Contracts are non-exclusive and may be concluded with multiple market participants.

Administrative

  • Contract terms, conditions and access procedures are uniform; individual negotiations are not conducted.

Buyer

Lots (1)

LOT-0001

Open-house pharmaceutical rebate agreements for Tamsulosin and Dutasteride

Non-exclusive rebate agreements under Sections 130a(8) and 130c(1) SGB V for medicines containing Tamsulosin and Dutasteride, ATC G04CA52. All interested pharmaceutical companies may join without a competitive selection decision. Medicines listed on the BfArM children’s medicines list under Section 35(5a) SGB V are excluded. Contracts may be concluded monthly, with a maximum duration ending no later than 31 May 2027, and may be automatically terminated if exclusive rebate contracts replace them.

SuppliesEU fundedElectronic submission

Location

Eisenberg, Germany

Duration

May 2025 - May 2027

Category

Pharmaceutical products

Deadline

Deadline Mar 31, 2027

Procurement Details

Publication date
10 Apr 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
236184-2025

Documents (1)

Similar tenders

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy